Emerging evidence for cannabis' role in opioid use disorder

B Wiese, AR Wilson-Poe - Cannabis and cannabinoid research, 2018 - liebertpub.com
Introduction: The opioid epidemic has become an immense problem in North America, and
despite decades of research on the most effective means to treat opioid use disorder (OUD) …

Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel

L Kohan, S Potru, AM Barreveld, M Sprintz… - Regional Anesthesia & …, 2021 - rapm.bmj.com
Background The past two decades have witnessed an epidemic of opioid use disorder
(OUD) in the USA, resulting in catastrophic loss of life secondary to opioid overdoses …

Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists

A Gillis, AB Gondin, A Kliewer, J Sanchez, HD Lim… - Science …, 2020 - science.org
Biased agonism at G protein–coupled receptors describes the phenomenon whereby some
drugs can activate some downstream signaling activities to the relative exclusion of others …

Opioid-induced constipation and bowel dysfunction: a clinical guideline

S Müller-Lissner, G Bassotti, B Coffin… - Pain …, 2017 - academic.oup.com
Objective To formulate timely evidence-based guidelines for the management of opioid-
induced bowel dysfunction. Setting Constipation is a major untoward effect of opioids …

Buprenorphine–an attractive opioid with underutilized potential in treatment of chronic pain

IK Khanna, S Pillarisetti - Journal of pain research, 2015 - Taylor & Francis
Despite proven clinical utility, buprenorphine has not been used widely for the treatment of
chronic pain. Questions about “ceiling effect” or bell-shaped curve observed for analgesia in …

Treating chronic pain: an overview of clinical studies centered on the buprenorphine option

MP Davis, G Pasternak, B Behm - Drugs, 2018 - Springer
The buprenorphine receptor binding profile is unique in that it binds to all three major opioid
receptors (mu, kappa, delta), and also binds to the orphan-like receptor, the receptor for …

Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression

MZ Imam, A Kuo, S Ghassabian, MT Smith - Neuropharmacology, 2018 - Elsevier
Opioids evoke analgesia through activation of opioid receptors (predominantly the μ opioid
receptor) in the central nervous system. Opioid receptors are abundant in multiple regions of …

[PDF][PDF] Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain

MP Davis - J Support Oncol, 2012 - academia.edu
Buprenorphine is an opioid that has a complex and unique pharmacology which provides
some advantages over other potent mu agonists. We review 12 reasons for considering …

Fentanyl formulations in the management of pain: an update

SA Schug, S Ting - Drugs, 2017 - Springer
Fentanyl is a synthetic, highly selective opioid with many desirable physicochemical
properties, including a high lipophilicity and predictable pharmacokinetics. These properties …

Biased versus partial agonism in the search for safer opioid analgesics

J Azevedo Neto, A Costanzini, R De Giorgio… - Molecules, 2020 - mdpi.com
Opioids such as morphine—acting at the mu opioid receptor—are the mainstay for treatment
of moderate to severe pain and have good efficacy in these indications. However, these …